Small Fiber Assessment by Cutaneous Silent Period

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

64 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-04-27

Study Completion Date

2021-10-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Our primary objective in this study is to investigate the cutaneous silent period (CSP) in normal subjects in the Egyptian population, as it was not carried out before in Egypt. The aim was to carry out the test in our unit to study the appropriate method, technique, and parameters of this new test so that we can apply it in future research. In addition, to obtain preliminary normative data of the test; onset latency, end latency, duration, and latency difference (LD) of CSP, as well as assess the effect of age, height, upper limb length, and gender on CSP values.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Diabetic Small Fiber Neuropathy: Clinical, Electrophysiological and Neurosonographic Study

NCT05993871

Small Fiber Neuropathy Diabetic Neuropathies Autonomic Neuropathy +3 more

COMPLETED

Utilizing the Michigan Neuropathy Screening Instrument for Early Detection of Diabetic Neuropathy

NCT06514846

Diabetic Polyneuropathy

RECRUITING

Effect of Different Ultrasound Doses on Median Nerve Conduction Parameters

NCT05233488

Entrapment Neuropathies

UNKNOWN NA

Skin Biopsy in the Diagnosis of Small Fiber Neuropathy in Chinese Patients With Diabetes

NCT04071535

Small Fiber Neuropathy Diabetic Neuropathies Diabetes Mellitus

UNKNOWN

The Relation Between Diabetic Neuropathy and Muscle Mass in Type 2 Diabetes Mellitus Patients

NCT06958302

Diabetic Neuropathy Sarcopenia

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Nerve conduction studies performed routinely in electromyoneurography laboratories deal mainly with large myelinated fast conducting nerve fibers. A reliable method allowing the study of small peripheral nerve fibers (Aδ \& C) would be of interest (Jovita et al., 2006). As they are initially affected and maybe the earliest exhibited sign of neuropathy.

In recent years, the cutaneous silent period (CSP) has received increased attention in health and disease. The CSP is an inhibitory spinal reflex that appears following strong electrical stimulation of the cutaneous nerve and causes suppression of voluntary muscular contraction for a certain period of time (Kofler et al., 2019). This action presents a reciprocal action to the nociceptive flexor withdrawal response (FWR) which serves as an 'excitatory reflex' increasing activity in primary flexor muscles. When taken into context, the interplay between the CSP and FWR can clearly be seen.

The evaluation of the CSP represents a useful electrophysiological method for investigating the function of small fibers by using standard electromyography equipment (Eckert et al., 2018).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Small Fiber Neuropathy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

CROSS_SECTIONAL

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

cutaneous silent period

form of Nerve conduction studies

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Healthy participants able to cooperate and to follow instructions.
* Participants having a normal value for electrophysiological parameters (Nerve conduction studies)
* Participants must be free from any musculoskeletal impairment of the limbs

Exclusion Criteria

* Participants with neurological disorders
* Participants with cognitive impairment
* Participants receiving medications that may affect the NCS
* Participants with small fiber neuropathy (burning sensation, pricking sensation, allodynia, and hyperalgesia)
* Participants with an abnormal value for Nerve conduction studies
* Participants with musculoskeletal impairment of the limbs

Minimum Eligible Age

20 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes